It’s been three-and-a-half years since generative AI exploded onto the scene. In this past year, progress has continued its relentless pace: Vibe coding took off, companies embraced agentic workflows, ...

Getting used to pressing the Command key instead of Control on a Mac may be one of the most difficult things to adapt to when switching from a Windows computer to something like an M2 Macbook Air. The ...

Researchers have developed a method to extract bio-oil from the surface fiber waste of date palm trees, an abundant, low-cost, and sustainable biomass resource generated by an estimated 150 million ...

Anthropic has purchased the stealth biotech AI startup Coefficient Bio in a $400 million stock deal, according to The Information and Eric Newcomer. Sources close to the deal confirmed to TechCrunch ...

At a time of ecological emergency, architecture cannot be separated from the extractive systems on which it depends. As the technosphere expands, linking material flows, energy consumption, and ...

Liège-based Bio‑Sourcing and Roanoke-based The Tiny Cargo Company inked a strategic collaboration to co‑develop orally delivered monoclonal antibody (mAb)-based therapies formulated using goat ...

A biologist takes inspiration from fungus-growing ants in his research with microbes that grow on roots in soil. Leafcutter ants, seen here on fungi, inspired Ulrich Mueller’s research on microbiome ...

[Maximilian Milovidov is a freshman at Columbia University and a member of TikTok's Youth Council. He used a large language model to edit this essay for length and a human to edit for content. This ...

I can't stand opening the Microsoft Store. It's slow to load, confusing to browse, and full of ads for things I don't care about. Luckily, thanks to a new feature, I don't have to open the Microsoft ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in early-stage funding to develop better drugs for pharmaceutical companies and open up ...

Jan 6 (Reuters) - Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic data to discover new drug candidates to send into human ...